Bill

Bill > S3496


US S3496

US S3496
Promoting ACCESS to Diagnostics Act Promoting Access to Critical Countermeasures by Ensuring Specimen Samples to Diagnostics Act


summary

Introduced
01/13/2022
In Committee
01/13/2022
Crossed Over
Passed
Dead
01/03/2023

Introduced Session

117th Congress

Bill Summary

A BILL To improve research and development of medical countermeasures for novel pathogens.

AI Summary

This bill, the Promoting ACCESS to Diagnostics Act, aims to improve research and development of medical countermeasures for novel pathogens. It has two key provisions: 1. Specimen Access: Within one year of enactment, the Secretary of Health and Human Services (HHS) must make publicly available policies and procedures for public and private entities to access specimens of, or containing, pathogens or suitable surrogates/alternatives. This is to support public health preparedness, response activities, and biomedical research for developing and validating medical products to address emerging infectious diseases. 2. Earlier Diagnostic Test Development: The bill amends the Public Health Service Act to allow the HHS Secretary to contract with public and private entities to increase capacity for the rapid development, validation, manufacture, and dissemination of diagnostic tests. This is to support immediate public health response activities for emerging infectious diseases with significant potential to cause a public health emergency.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 01/13/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...